NCT05854927View on ClinicalTrials.gov

Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)

Not yet recruitingOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Giant Cell Arteritis
Interventions
DIAGNOSTIC_TEST

3D T1 MRI sequences injected with fat saturation and black blood

3D T1 MRI sequences injected with fat saturation and black blood

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT05854927 - Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA) | Biotech Hunter | Biotech Hunter